Figure 2a Figure 2b
Figure 2. Network geometry for the efficacy outcome (a) and
safety outcome (b). Each node represents one strain-specific
intervention. The size of the node is proportional to the number of
participants randomly assigned to the intervention, and the thickness of
the lines is proportional to the number of trials comparing the two
interventions. The largest node is placebo, with a total of 303 patients
for the efficacy outcome and 370 patients for the safety outcome across
all studies.